What are Neuropace, Inc.'s total assets?

Neuropace, Inc. (NPCE) holds $98.9M in total assets, down 10.3% year over year.

How much debt does Neuropace, Inc. have?

Neuropace, Inc. carries $70.5M in total debt against $14.5M of shareholders' equity, a debt-to-equity ratio of 4.87.

How much cash does Neuropace, Inc. have?

Neuropace, Inc. holds $15.6M in cash and equivalents.

Can Neuropace, Inc. cover its short-term obligations?

Its current ratio is 5.38 — current assets exceed current liabilities.

Where does Neuropace, Inc.'s balance sheet data come from?

Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Neuropace, Inc. NPCE Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$21.81M+61.0%	$13.55M-25.5%	$18.18M+170%	$6.73M-65.2%
Short-term investments	$39.37M+0.1%	$39.33M-18.7%	$48.4M-31.6%	$70.8M-26.5%
Restricted cash	$122K0.0%	$122K0.0%	$122K0.0%	$122K0.0%
Accounts receivable, net	$58.61M+23.9%	$47.29M+8.3%	$43.66M+32.7%	$32.89M+11.1%
Inventories	$64.96M+34.6%	$48.24M+15.6%	$41.74M+19.9%	$34.82M+20.1%
Raw materials	$6.21M+60.4%	$3.87M-5.3%	$4.09M+45.1%	$2.82M+26.3%
Work in process	$2.78M+29.0%	$2.15M+244%	$627K-58.8%	$1.52M+73.3%
Finished goods	$7.91M+7.5%	$7.36M+13.2%	$6.5M+21.0%	$5.37M+14.0%
Prepaid expenses and other current assets	$7.58M-14.0%	$8.81M-1.8%	$8.97M-17.3%	$10.85M+0.2%
Total current assets	$94.07M+15.7%	$81.34M-12.3%	$92.72M-5.1%	$97.71M-26.4%
Property and equipment, net	$1.13M+6.9%	$1.05M+4.9%	$1M-5.7%	$1.06M+76.5%
Accumulated depreciation	$8.21M+2.9%	$7.97M+2.7%	$7.77M-11.0%	$8.72M+3.2%
Operating lease right-of-use assets	8.5%0.0%	8.5%0.0%	8.5%0.0%	8.5%—
Deferred tax assets	$46.03M+9.5%	$42.04M+0.4%	$41.86M+2.4%	$40.88M+14.3%
Other non-current assets	$113K+653%	$15K0.0%	$15K-28.6%	$21K0.0%
Total investment securities	$39.37M+0.1%	$39.33M-18.7%	$48.4M-31.6%	$70.8M-26.5%
Allowance for credit losses	$1.98M+41.5%	$1.4M-14.3%	$1.63M+38.4%	$1.18M-26.3%
Total assets	$105.57M+11.5%	$94.65M-12.1%	$107.65M-5.7%	$114.11M-14.6%
Accounts payable	$15.57M+45.9%	$10.67M+48.7%	$7.18M+1.7%	$7.05M+38.7%
Accrued expenses	$10.49M+26.3%	$8.31M-13.9%	$9.66M+68.0%	$5.75M-12.2%
Deferred revenue	$141K-74.6%	$555K-49.1%	$1.09M—	$0—
Operating lease liabilities, current	$2.12M+13.8%	$1.86M+14.3%	$1.63M+15.0%	$1.42M—
Accrued interest	$484K—	$0-100%	$5.03M+30.7%	$3.85M+47.2%
Total current liabilities	$17.81M+17.5%	$15.16M-6.6%	$16.23M+47.9%	$10.98M+18.0%
Deferred tax liabilities	$2.66M-11.7%	$3.01M-12.3%	$3.44M-12.1%	$3.91M—
Long-term debt	$58.88M-1.1%	$59.53M+4.5%	$56.95M+7.6%	$52.91M+6.2%
Operating lease liabilities, non-current	$9.84M-17.7%	$11.95M-13.5%	$13.81M-10.5%	$15.44M—
Operating Lease Liabilities (Total)	$11.95M-13.5%	$13.81M-10.5%	$15.44M-8.4%	$16.86M+125%
Total liabilities	$0—	$0—	$0—	$0—
Preferred stock	$0—	$0—	$0—	$0—
Common stock	200M0.0%	200M0.0%	200M0.0%	200M0.0%
Additional paid-in capital	$571.41M+6.0%	$538.93M+2.8%	$524.44M+3.5%	$506.71M+1.8%
Retained earnings	-$552.42M-4.0%	-$530.95M-5.4%	-$503.81M-7.0%	-$470.85M-11.1%
Total stockholders' equity	$19.03M+138%	$8.01M-61.2%	$20.65M-40.6%	$34.78M-52.7%
Total liabilities and stockholders' equity	$105.57M+11.5%	$94.65M-12.1%	$107.65M-5.7%	$114.11M-14.6%
Cash Cash Equivalents And Short Term Investments	$61.1M+15.7%	$52.8M-20.6%	$66.5M-14.1%	$77.4M-33.0%
Deferred Tax Assets and Other Non-Current Assets	$1.7M+32.6%	$1.28M-25.4%	$1.72M+13.0%	$1.52M+94.8%
Net Investment in Lease	$10.13M-14.4%	$11.84M-11.7%	$13.41M-9.7%	$14.84M—
Operating lease right-of-use assets	$10.13M-14.4%	$11.84M-11.7%	$13.41M-9.7%	$14.84M—
Other non-current assets	$113K+653%	$15K0.0%	$15K-28.6%	$21K0.0%
Property, plant and equipment at cost	$9.33M+3.4%	$9.03M+2.9%	$8.77M-10.4%	$9.79M+8.0%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$39.37M+0.1%	$39.33M-18.7%	$48.4M-31.6%	$70.8M-26.5%
Operating Lease Right-of-Use Assets in Other Assets	$10.13M-14.4%	$11.84M-11.7%	$13.41M-9.7%	$14.84M—
Software and Technology Licenses, Net	$113K+653%	$15K0.0%	$15K-28.6%	$21K0.0%
Tax Credit Carryforward Valuation Allowance	$85.71M+9.6%	$78.19M+8.2%	$72.26M+11.6%	$64.78M+24.6%
Accrued Contingent Liabilities	$0—	$0—	$0—	$0—
Accrued Manufacturing Costs	$10.49M+26.3%	$8.31M-13.9%	$9.66M+68.0%	$5.75M-12.2%
Other Commercial Liabilities	$13.34M+36.3%	$9.79M-12.5%	$11.18M+50.8%	$7.41M-6.4%
Accrued Liabilities, Current	$13.34M+36.3%	$9.79M-12.5%	$11.18M+50.8%	$7.41M-6.4%
Compensation and benefits	$10.49M+26.3%	$8.31M-13.9%	$9.66M+68.0%	$5.75M-12.2%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$3.12M+3.0%	$3.03M+3.0%	$2.94M+3.0%	$2.86M—
Operating Lease Liability Payments - 2025 (Lessee)	$3.12M-2.9%	$3.22M+3.0%	$3.12M+3.0%	$3.03M—
Lease Liability Payments - Due Year Two	$3.12M+3.0%	$3.03M+3.0%	$2.94M+3.0%	$2.86M—
Lease Liability Payments - Due Year Three	$3.22M+3.0%	$3.12M+3.0%	$3.03M+3.0%	$2.94M—
Lease Liability Payments - Due Year Four	——	$3.22M+3.0%	$3.12M+3.0%	$3.03M—
Lease Liability Payments - Remainder of Fiscal Year	$3.03M+3.0%	$2.94M+3.0%	$2.86M+3.0%	$2.77M—
Operating Lease Liability Payments Due	$14.38M-17.0%	$17.33M-14.2%	$20.18M-12.1%	$22.96M—
Operating Lease Liability - Undiscounted Excess Amount	$2.43M-30.8%	$3.51M-25.9%	$4.74M-22.3%	$6.1M—
Professional Service Fees Payable	$374K+648%	$50K+66.7%	$30K-86.8%	$227K+108%
Operating Lease Liability Payments - 2026 (Lessee)	$3.22M+3.0%	$3.12M+3.0%	$3.03M+3.0%	$2.94M—
Operating Lease Liability Payments - 2027 (Lessee)	$3.31M0.0%	$3.31M+3.0%	$3.22M+3.0%	$3.12M—
Operating Lease Liability Payments - 2028 (Lessee)	$3.31M+3.0%	$3.22M+3.0%	$3.12M+3.0%	$3.03M—
Operating Lease Liability Payments - 2029 (Lessee)	$3.31M0.0%	$3.31M+3.0%	$3.22M+3.0%	$3.12M—
Lease Liability Payments - Due After Year Five	$1.7M0.0%	$1.7M-66.0%	$5.02M-39.1%	$8.23M—
Operating Lease Liability Payments - Thereafter (Lessee)	$1.7M0.0%	$1.7M-66.0%	$5.02M-39.1%	$8.23M—
Total debt	$70.84M-3.4%	$73.34M+1.3%	$72.4M+3.8%	$69.77M+21.7%
Unrecognized Tax Benefits	$2.32M+11.1%	$2.09M+20.5%	$1.73M+8.1%	$1.6M+7.5%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	33.6M+11.4%	30.1M+8.3%	27.8M+11.1%	25M+2.4%
Common Stock Shares Outstanding	$22.51M—	——	——	——
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$34K+13.3%	$30K+7.1%	$28K+12.0%	$25K+4.2%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Number of Exercisable Options	$22.51M+1,335%	$1.57M-3.4%	$1.62M-3.5%	$1.68M+62.6%
Number of Vested and Expected to Vest Options	2.6M+9.7%	2.4M-8.5%	2.6M-24.9%	3.4M+13.4%
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	2.6M+9.7%	2.4M-8.5%	2.6M-24.9%	3.4M+13.4%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$15.8M+5.3%	$15M-6.3%	$16M-19.2%	$19.8M—
Shares Reserved for Future Issuance Under Stock Plans	7.1M+9.2%	6.5M-3.1%	6.7M-4.8%	7.1M+13.4%
Unrealized Gains on Investments	$200K+100%	$100K—	——	-$1.11M-263%
Weighted Average Exercise Price of Outstanding Options	$7.09+18.0%	$6.01+33.3%	$4.51+24.9%	$3.61+38.3%
Weighted Average Exercise Price of Vested and Expected to Vest Options	$7.09+18.0%	$6.01+33.3%	$4.51+24.9%	$3.61+38.3%
Cumulative Cost Basis	$9.33M+3.4%	$9.03M+2.9%	$8.77M-87.8%	$71.9M-25.6%
Accrued and Employee-related Liabilities, Current	$13.34M+36.3%	$9.79M-12.5%	$11.18M+50.8%	$7.41M-6.4%
Inventory purchases	$874K+52.0%	$575K-2.2%	$588K-23.0%	$764K+204%
Professional service fees	$374K+648%	$50K+66.7%	$30K-86.8%	$227K+108%
Gross Unrealized Gains	$200K+100%	$100K—	——	——
Common stock, capital shares reserved for future issuance	$7.13M+9.2%	$6.52M-3.1%	$6.73M-4.8%	$7.08M+13.4%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%
Common stock, shares issued (in shares)	$33.57M+11.4%	$30.15M+8.3%	$27.82M+11.1%	$25.05M+2.4%
Common Stock, Shares, Outstanding	$33.57M+11.4%	$30.15M+8.3%	$27.82M+11.1%	$25.05M+2.4%
Deferred Tax Liabilities, Gross	$2.66M-11.7%	$3.01M-12.3%	$3.44M-12.1%	$3.91M—
Disallowed business interest expense carryforward	$6.71M+16.7%	$5.75M+14.2%	$5.03M+30.7%	$3.85M+47.2%
Deferred Tax Assets, Gross	$88.37M+8.8%	$81.2M+7.3%	$75.7M+10.2%	$68.69M+32.1%
Deferred Tax Assets, Net of Valuation Allowance	$0—	$0—	$0—	$0—
Operating lease liability	$3.08M-12.5%	$3.52M-11.2%	$3.96M-10.9%	$4.44M—
Deferred Tax Assets, Operating Loss Carryforwards	$46.03M+9.5%	$42.04M+0.4%	$41.86M+2.4%	$40.88M+14.3%
Fixed assets and inventory	$0-100%	$28K-81.5%	$151K-5.0%	$159K+32.5%
Research and development expenditures, capitalized for tax	$12.07M-1.7%	$12.28M+48.5%	$8.27M+81.3%	$4.56M—
R&D credit carryforward	$16.81M+12.8%	$14.9M+14.0%	$13.07M+8.1%	$12.09M+8.7%
Temporary differences related to Texas Margin Tax	$1.98M+41.5%	$1.4M-14.3%	$1.63M+38.4%	$1.18M-26.3%
Deferred Tax Assets, Valuation Allowance	$85.71M+9.6%	$78.19M+8.2%	$72.26M+11.6%	$64.78M+24.6%
Deferred Tax Liabilities, Operating Lease Right-of-Use Asset	$2.61M-13.5%	$3.01M-12.3%	$3.44M-12.1%	$3.91M—
Cost not yet recognized	$15.8M+5.3%	$15M-6.3%	$16M-19.2%	$19.8M—
Indemnification liability accrued for officers and directors	$0—	$0—	$0—	$0—
Raw materials	$6.21M+60.4%	$3.87M-5.3%	$4.09M+45.1%	$2.82M+26.3%
Investments Fair Value Disclosure	$39.37M+0.1%	$39.33M-18.7%	$48.4M-31.6%	$70.8M-26.5%
Lessee Operating Lease Liability Payments Due	$14.38M-17.0%	$17.33M-14.2%	$20.18M-12.1%	$22.96M—
Lessee Operating Lease Liability Undiscounted Excess Amount	$2.43M-30.8%	$3.51M-25.9%	$4.74M-22.3%	$6.1M—
Loss Contingency Accrual	$0—	$0—	$0—	$0—
Operating Lease Weighted Average Discount Rate Percent	$0.090.0%	$0.090.0%	$0.090.0%	$0.09—
Other accrued liabilities	$859K+61.5%	$532K-41.3%	$907K+34.4%	$675K+28.3%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Percentage increase in purchase commitment	——	——	——	——
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	$1.5M-11.8%	$1.7M—	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$7.09+18.0%	$6.01+33.3%	$4.51+24.9%	$3.61+38.3%
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$1.79M+14.2%	$1.57M-3.4%	$1.62M-3.5%	$1.68M+62.6%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$2.6M+9.7%	$2.37M-8.5%	$2.59M-24.9%	$3.45M+13.4%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	$2.6M+9.7%	$2.37M-8.5%	$2.59M-24.9%	$3.45M+13.4%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$7.09+18.0%	$6.01+33.3%	$4.51+24.9%	$3.61+38.3%
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	$22.51M—	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$22.51M—	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$5.71+26.6%	$4.51+6.9%	$4.22+98.1%	$2.13+233%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$18.03M—	——	——	——
Unrecognized tax benefits	$2.32M+11.1%	$2.09M+20.5%	$1.73M+8.1%	$1.6M+7.5%
Vendor-related expenses	$256K-20.0%	$320K—	——	——
Remainder of Fiscal Year 2024	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Neuropace, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Neuropace, Inc.'s total assets?: Neuropace, Inc. (NPCE) holds $98.9M in total assets, down 10.3% year over year.
How much debt does Neuropace, Inc. have?: Neuropace, Inc. carries $70.5M in total debt against $14.5M of shareholders' equity, a debt-to-equity ratio of 4.87.
How much cash does Neuropace, Inc. have?: Neuropace, Inc. holds $15.6M in cash and equivalents.
Can Neuropace, Inc. cover its short-term obligations?: Its current ratio is 5.38 — current assets exceed current liabilities.
Where does Neuropace, Inc.'s balance sheet data come from?: Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.